172 related articles for article (PubMed ID: 30938880)
61. Clear cell sarcoma of soft tissue: a clinicopathologic, immunohistochemical, and molecular analysis of 33 cases.
Hisaoka M; Ishida T; Kuo TT; Matsuyama A; Imamura T; Nishida K; Kuroda H; Inayama Y; Oshiro H; Kobayashi H; Nakajima T; Fukuda T; Ae K; Hashimoto H
Am J Surg Pathol; 2008 Mar; 32(3):452-60. PubMed ID: 18300804
[TBL] [Abstract][Full Text] [Related]
62. Diagnostic method for the detection of KIF5B-RET transformation in lung adenocarcinoma.
Go H; Jung YJ; Kang HW; Park IK; Kang CH; Lee JW; Ju YS; Seo JS; Chung DH; Kim YT
Lung Cancer; 2013 Oct; 82(1):44-50. PubMed ID: 23932363
[TBL] [Abstract][Full Text] [Related]
63. A spindle cell neoplasm with MYH9::EGFR fusion and co-expression of S100 and CD34, further expanding the family of kinase fusion positive spindle cell neoplasms.
Caprini E; Verkhovskaia S; Casini B; Testi A; Dagrada GP; Palese E; Rahimi S
Genes Chromosomes Cancer; 2023 Aug; 62(8):483-488. PubMed ID: 36849873
[TBL] [Abstract][Full Text] [Related]
64. Hybrid schwannoma/perineurioma: clinicopathologic analysis of 42 distinctive benign nerve sheath tumors.
Hornick JL; Bundock EA; Fletcher CD
Am J Surg Pathol; 2009 Oct; 33(10):1554-61. PubMed ID: 19623031
[TBL] [Abstract][Full Text] [Related]
65. Novel
Yeung MCF; Lam AYL; Shek TWH
Int J Surg Pathol; 2022 Sep; 30(6):682-688. PubMed ID: 35156861
[TBL] [Abstract][Full Text] [Related]
66. Calcifying Spindle Cell Soft Tissue Tumor With SOX10::PLAG1 Fusion: A Case Report of a Morphologically Distinctive and Potentially Novel Soft Tissue Tumor.
Kosemehmetoglu K; Mosaieby E; Šteiner P; Vaněček T; Baranovska-Andrigo V; Michal M
Genes Chromosomes Cancer; 2024 Jun; 63(6):e23249. PubMed ID: 38884173
[TBL] [Abstract][Full Text] [Related]
67. Detection of RET (rearranged during transfection) variants and their downstream signal molecules in RET rearranged lung adenocarcinoma patients.
Kim JO; Shin JY; Kim MY; Son KH; Jung CK; Kim TJ; Kim SY; Park JK; Sung SW; Bae SJ; Min HJ; Kang JH
Surg Oncol; 2018 Mar; 27(1):106-113. PubMed ID: 29549897
[TBL] [Abstract][Full Text] [Related]
68. Emerging soft tissue tumors with kinase fusions: An overview of the recent literature with an emphasis on diagnostic criteria.
Antonescu CR
Genes Chromosomes Cancer; 2020 Aug; 59(8):437-444. PubMed ID: 32243019
[TBL] [Abstract][Full Text] [Related]
69. RET fusion as a novel driver of medullary thyroid carcinoma.
Grubbs EG; Ng PK; Bui J; Busaidy NL; Chen K; Lee JE; Lu X; Lu H; Meric-Bernstam F; Mills GB; Palmer G; Perrier ND; Scott KL; Shaw KR; Waguespack SG; Williams MD; Yelensky R; Cote GJ
J Clin Endocrinol Metab; 2015 Mar; 100(3):788-93. PubMed ID: 25546157
[TBL] [Abstract][Full Text] [Related]
70. Dermal lipofibromatosis-like neural tumor.
Llamas-Velasco M; Itlinger-Monshi B; Flucke U; Mentzel T
J Cutan Pathol; 2022 Jun; 49(6):525-531. PubMed ID: 35195930
[TBL] [Abstract][Full Text] [Related]
71. A novel BRD4-LEUTX fusion in a pediatric sarcoma with epithelioid morphology and diffuse S100 expression.
Barresi S; Giovannoni I; Rossi S; Stracuzzi A; Quacquarini D; Cafferata B; Piscitelli D; De Leonardis F; Marzullo A; Alaggio R
Genes Chromosomes Cancer; 2021 Sep; 60(9):647-652. PubMed ID: 34041805
[TBL] [Abstract][Full Text] [Related]
72. RET fusions define a unique molecular and clinicopathologic subtype of non-small-cell lung cancer.
Wang R; Hu H; Pan Y; Li Y; Ye T; Li C; Luo X; Wang L; Li H; Zhang Y; Li F; Lu Y; Lu Q; Xu J; Garfield D; Shen L; Ji H; Pao W; Sun Y; Chen H
J Clin Oncol; 2012 Dec; 30(35):4352-9. PubMed ID: 23150706
[TBL] [Abstract][Full Text] [Related]
73. Expanding the molecular signature of ossifying fibromyxoid tumors with two novel gene fusions: CREBBP-BCORL1 and KDM2A-WWTR1.
Kao YC; Sung YS; Zhang L; Chen CL; Huang SC; Antonescu CR
Genes Chromosomes Cancer; 2017 Jan; 56(1):42-50. PubMed ID: 27537276
[TBL] [Abstract][Full Text] [Related]
74. Novel rearrangements involving the RET gene in papillary thyroid carcinoma.
Staubitz JI; Schad A; Springer E; Rajalingam K; Lang H; Roth W; Hartmann N; Musholt TJ
Cancer Genet; 2019 Jan; 230():13-20. PubMed ID: 30466862
[TBL] [Abstract][Full Text] [Related]
75. A mass spectrometry assay to simultaneously analyze ROS1 and RET fusion gene expression in non-small-cell lung cancer.
Wijesinghe P; Bepler G; Bollig-Fischer A
J Thorac Oncol; 2015 Feb; 10(2):381-6. PubMed ID: 25384172
[TBL] [Abstract][Full Text] [Related]
76.
Cordier F; Loontiens S; Van der Meulen J; Lapeire L; van Ramshorst GH; Sys G; Van Dorpe J; Creytens D
Int J Surg Pathol; 2024 Feb; 32(1):133-139. PubMed ID: 37141633
[TBL] [Abstract][Full Text] [Related]
77. Transcript level modulates the inherent oncogenicity of RET/PTC oncoproteins.
Richardson DS; Gujral TS; Peng S; Asa SL; Mulligan LM
Cancer Res; 2009 Jun; 69(11):4861-9. PubMed ID: 19487296
[TBL] [Abstract][Full Text] [Related]
78. NCOA4-RET fusion in colorectal cancer: Therapeutic challenge using patient-derived tumor cell lines.
Kim SY; Oh SO; Kim K; Lee J; Kang S; Kim KM; Lee W; Kim ST; Nam DN
J Cancer; 2018; 9(17):3032-3037. PubMed ID: 30210625
[TBL] [Abstract][Full Text] [Related]
79. Recurrent BRAF Gene Rearrangements in Myxoinflammatory Fibroblastic Sarcomas, but Not Hemosiderotic Fibrolipomatous Tumors.
Kao YC; Ranucci V; Zhang L; Sung YS; Athanasian EA; Swanson D; Dickson BC; Antonescu CR
Am J Surg Pathol; 2017 Nov; 41(11):1456-1465. PubMed ID: 28692601
[TBL] [Abstract][Full Text] [Related]
80. Molecular Analysis of Gene Fusions in Bone and Soft Tissue Tumors by Anchored Multiplex PCR-Based Targeted Next-Generation Sequencing.
Lam SW; Cleton-Jansen AM; Cleven AHG; Ruano D; van Wezel T; Szuhai K; Bovée JVMG
J Mol Diagn; 2018 Sep; 20(5):653-663. PubMed ID: 30139549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
